Searchable abstracts of presentations at key conferences in endocrinology

ea0044p84 | Clinical biochemistry | SFEBES2016

Cost-effective strategies to accelerate diagnosis and management of endocrine disorders in the outpatient setting

Sivapackianathan Rasheeta , Siddiqi Ahmed , Gouveia C. , Metcalfe Karl

Introduction: The assessment of a new patient in the medical outpatients relies on thorough history taking as well as clinical examination. In particular, biochemical tests are pivotal in the diagnosis of endocrine conditions. Historically, our unit only mostly performed biochemical tests after new patients attended clinic. We proposed that diagnosis and management would be more efficient if this system was reverted, with the aim of minimising the number of clinic appointments...

ea0028p247 | Pituitary | SFEBES2012

A case series of corticotroph macroadenomas and Cushing’s: clinical characteristics and management

O'Toole Sam , Metcalfe Karl , Plowman Piers , Evanson Jane , Carpenter Robert , Drake Will

Background: Pituitary macroadenomas are an uncommon cause of Cushing’s disease. They present with a higher cortisol burden, are more aggressive and harder to cure and manage than microadenomas.Aims: To review the demographics, clinical features, biochemistry, radiology and required treatment modalities of a single-centre case series of corticotroph macroadenomas.Methods: Retrospective analysis and review of the case records of...

ea0015p91 | Clinical practice/governance and case reports | SFEBES2008

Growth hormone replacement in patients with treated germ cell tumours: safety issues

Chung Teng-Teng LL , Kelly Phillip , Metcalfe Karl , Akker Scott , Drake William , Monson John

The potential for primary tumour relapse is an important consideration during GH replacement therapy (GHR). We report 3 cases of relapse of intra cranial germ cell tumour (GCT) during GHR.Patient 1: An 11 year-old female presenting with visual loss and short stature due to a suprasellar malignant teratoma. She was successfully treated with bleomycin, etoposide and cisplatinum (BEP) and intrathecal chemotherapy. She suffered a first relapse two years late...

ea0044ep30 | (1) | SFEBES2016

Hypercalcaemia induced psychosis due to primary hyperparathyroidism in pregnancy

Thomas Alice , Gunganah Kirun , Rayanagoudar Girish , Williams Eliot , Hanson Philippa , Drake Williams , Berney Daniel , Parvanta Laila , Kirwin Simon , Metcalfe Karl

Background: Primary hyperparathyroidism is the third most common endocrine condition in pregnancy after thyroid disease and diabetes. Untreated hypercalcaemia due to primary hyperparathyroidism increases the risk of miscarriage, intrauterine death and preterm labour. Pharmacological and surgical limitations in pregnancy often make diagnosing and managing this condition challenging. We report a complex case of hypercalcaemia-induced -psychosis due to primary hyperparathyroidism...